Foley Hoag Represents Organogenesis in Completed Merger with Avista Healthcare Public Acquisition Corp.

December 11, 2018

Foley Hoag LLP represented Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, in the completion of its merger with Avista Healthcare Public Acquisition Corp. (Nasdaq: AHPA), a publicly traded special purpose acquisition company. 

Affiliates of Avista Capital Partners, a leading private equity firm, have invested $92 million in the combined company in conjunction with the transaction. Organogenesis’ management team, led by Gary S. Gillheeney, Sr., will run the combined company.

Foley Hoag partners William Kolb and Stacie Aarestad and associates Ryan Rourke Reed, Remi Kathawa, Justin Beegle and Caroline Samp represented Organogenesis in the transaction.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and business services professionals contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit or follow @FoleyHoag on Twitter.